APA (7th ed.) Citation

Philipson, T. J., Zhao, Q., Zhang, D., Fujibayashi, K., & Johnson, H. (2025). Follow-On Cancer Drugs Target Earlier Stages Than Initial Drugs: Implications Of The IRA. Health Affairs, 44(12), 1448. https://doi.org/10.1377/hlthaff.2025.00627

Chicago Style (17th ed.) Citation

Philipson, Tomas J., Qi Zhao, Deyu Zhang, Kira Fujibayashi, and Heather Johnson. "Follow-On Cancer Drugs Target Earlier Stages Than Initial Drugs: Implications Of The IRA." Health Affairs 44, no. 12 (2025): 1448. https://doi.org/10.1377/hlthaff.2025.00627.

MLA (9th ed.) Citation

Philipson, Tomas J., et al. "Follow-On Cancer Drugs Target Earlier Stages Than Initial Drugs: Implications Of The IRA." Health Affairs, vol. 44, no. 12, 2025, p. 1448, https://doi.org/10.1377/hlthaff.2025.00627.